New scanner aims to cut repeat breast cancer surgeries

NCT ID NCT07352930

First seen Jun 26, 2026 · Last updated Jun 30, 2026 · Updated 3 times

Summary

This trial tests a new device called the EndoSCell Scanner, which uses fluorescence imaging to help surgeons see if any cancer cells remain after removing a breast tumor. About 172 women with breast cancer will have their surgical cavity scanned during surgery. If the scanner detects possible leftover cancer, the surgeon can remove more tissue right away. The goal is to lower the chance of needing a second surgery to clear remaining cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
EndoSCell Scanner (ES Scanner) device
What this could lead to
If successful, this device could help surgeons remove all cancer cells during breast-conserving surgery, reducing the need for a second operation.
What could go wrong
This is an early-stage trial with only 172 participants, so results may not apply to all patients. The device's accuracy in detecting cancer cells is still being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CONSERVING SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Guangdong Provincial People's Hospital

    RECRUITING

    Guangzhou, Guangdong, 510080, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.